A bill to amend the Controlled Substances Act to define currently accepted medical use with severe restrictions, and for other purposes.

3/13/2024, 10:15 AM

Congressional Summary of S 689

This bill provides for the classification of drugs or other substances that are part of approved breakthrough therapies as schedule II controlled substances under the Controlled Substances Act. (Schedule II controlled substances are substances that have a high potential for abuse but have a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions.)

Current Status of Bill S 689

Bill S 689 is currently in the status of Bill Introduced since March 7, 2023. Bill S 689 was introduced during Congress 118 and was introduced to the Senate on March 7, 2023.  Bill S 689's most recent activity was Read twice and referred to the Committee on the Judiciary. as of March 7, 2023

Bipartisan Support of Bill S 689

Total Number of Sponsors
1
Democrat Sponsors
1
Republican Sponsors
0
Unaffiliated Sponsors
0
Total Number of Cosponsors
4
Democrat Cosponsors
1
Republican Cosponsors
3
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill S 689

Primary Policy Focus

Crime and Law Enforcement

Potential Impact Areas

Health

Alternate Title(s) of Bill S 689

A bill to amend the Controlled Substances Act to define currently accepted medical use with severe restrictions, and for other purposes.A bill to amend the Controlled Substances Act to define currently accepted medical use with severe restrictions, and for other purposes.
Start holding our government accountable!

Comments